Treatment of stage IV non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines
about
Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yesTreatment of advanced squamous cell carcinoma of the lung: a reviewRobotic-Assisted Videothoracoscopic Surgery of the LungEffects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumorsSurvival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel.Liquid biopsy genotyping in lung cancer: ready for clinical utility?Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer.The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer.Surgical management of advanced non-small cell lung cancer.ATS Core Curriculum 2014: part I. Adult pulmonary medicine.A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond ProgressionEpidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung.Effects of multidisciplinary team care on the survival of patients with different stages of non-small cell lung cancer: a national cohort study.C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool: an observational study.Combining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody ResponseChemotherapeutic Response and Prognosis among Lung Cancer Patients with and without Depression.Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung CancerA retrospective analysis of safety and efficacy of weekly nab-paclitaxel as second-line chemotherapy in elderly patients with advanced squamous non-small-cell lung carcinoma.Capilliposide from Lysimachia capillipes inhibits AKT activation and restores gefitinib sensitivity in human non-small cell lung cancer cells with acquired gefitinib resistance.Molecular biology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Who are appropriate surgical candidates among patients with oligometastatic non-small cell lung cancer?Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and TherapyAntiangiogenic agents and chemotherapy in advanced non-small cell lung cancer: a clinical perspective.Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology ResearcTyrosine kinase inhibitors for epidermal growth factor receptor gene mutation-positive non-small cell lung cancers: an update for recent advances in therapeutics.Emerging paradigms in targeted treatments for Asian patients with NSCLC.Maintenance therapy in non-small cell lung cancer.Adjuvant therapy following surgery in non-small cell lung cancer (NSCLC).Pharmacoeconomic benefit of cisplatin and etoposide chemoregimen for metastatic non small cell lung cancer: An Indian study[Recombinant Human Endostatin in the Treatment of Advanced Lung Squamous Cell Carcinoma].Epidermal growth factor receptor gene mutation as risk factor for recurrence in patients with surgically resected lung adenocarcinoma: a matched-pair analysis.Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival†.Enhanced antitumor effect on intrapulmonary tumors of docetaxel lung-targeted liposomes in a rabbit model of VX2 orthotopic lung cancer.Lung cancer adrenal gland metastasis: Optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing.Recent advances in the management of non-small cell lung cancer.Post-recurrence survival analysis of stage I non-small-cell lung cancer.Identification of miRNAs as non-invasive biomarkers for early diagnosis of lung cancers.The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.
P2860
Q26766180-7D6AF4E4-3D8F-4115-BCC1-8E161F0F1427Q26775392-6A113DF7-2B03-47DA-9CE8-503AF626E6BCQ26782241-E7587E08-D820-4552-92A3-6DA260FC4946Q26799046-7DBF69AB-00EF-44AD-9811-E9D712D189FBQ33423320-0CDAE8DB-9EDC-4585-878B-7558C3BB09BAQ33567037-23968395-1F3C-4B0E-9886-02F619CCD8CDQ33572258-4523F7E5-3F14-4214-9A75-2402897C01BCQ33632386-CFD4DDC3-EB4B-4566-9442-69F93ADB5FAAQ33658215-F6EE6A9C-14A7-4877-9603-81E7C93C5882Q33786162-F947383E-31A6-4738-BD4B-80C123546EA8Q33868401-353CAEA2-1261-4FC2-A944-1EE83FA53DA1Q34650994-E2F9FD4C-F58A-4B1C-A5A3-A1A6BC630AADQ34781380-EA49617C-7A9D-4F37-80D7-384F913C566CQ35598608-755DB9DA-628E-4C97-B025-0F814CCE390DQ36009077-5238980E-EEDD-4FEA-89AE-D92880C50F70Q36148294-03F71C6B-55C9-4AE3-A922-86FF3AA5678DQ36190128-DA6B02F4-A711-48E4-B5CC-A6F614361B92Q36352827-C3139E0F-130E-4572-B63D-525FF1238A5EQ36617748-98871285-EC0D-434F-BA32-EE76EC780D83Q37571930-C3509BC7-31EF-47AC-8627-BCFEAC6A06EAQ37653893-BDDD6547-79B0-4643-871A-8DB40B5E443AQ37677580-73F4779D-F7B7-4EAD-A7CA-28C7489F2976Q37689802-9DF3E87F-895A-4B30-985B-0FB1705253BCQ38153445-62DE1BAA-3F7A-4BEC-B5EE-DD7F92B0B955Q38389182-8CC954F2-0B77-43B0-A1C2-8E492F2236E3Q38412163-B98BC9C3-8704-4783-A492-AFA009173F41Q38439446-05B940AB-9172-4F09-88FC-1AA3C1739EF7Q38509236-D8DA6D27-4D7B-4E55-8823-31E80F4946F9Q39012785-A8B3ADF8-A7F5-4CA3-911B-DE301CF5E13AQ39145896-D0C9F36A-B2D2-46A9-A041-70E4F74614E7Q40530443-51826F64-DC32-4D43-9ED8-F26264FC2CAAQ40756893-31896B49-CB08-4CF0-AE6A-9D3503A33531Q41557929-2514FF80-72C0-4FCC-99A0-E6090E59AFBFQ41564913-A6AA127F-0F8C-4B0D-B608-C70BF12F5456Q46092645-E9D5E6CF-60CB-48B5-A121-BB83D229DF4DQ47105316-42710CFE-0B63-442C-8350-CBD86F99CA80Q48006952-40CF201A-C909-40CA-A606-70119CF5E406Q48440253-BA8B4E42-67D4-4015-A000-51C0548575C0Q49980448-AECEF581-6E73-41B6-BC8F-9EEEB16BB19DQ50958792-9CB2FD48-88B7-4520-BCC9-E7557F02B6A4
P2860
Treatment of stage IV non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Treatment of stage IV non-smal ...... d clinical practice guidelines
@ast
Treatment of stage IV non-smal ...... d clinical practice guidelines
@en
type
label
Treatment of stage IV non-smal ...... d clinical practice guidelines
@ast
Treatment of stage IV non-smal ...... d clinical practice guidelines
@en
prefLabel
Treatment of stage IV non-smal ...... d clinical practice guidelines
@ast
Treatment of stage IV non-smal ...... d clinical practice guidelines
@en
P2093
P2860
P356
P1433
P1476
Treatment of stage IV non-smal ...... d clinical practice guidelines
@en
P2093
Belinda Ireland
Lecia VanDam Sequist
Mark A Socinski
Thomas A Hensing
Thomas E Stinchcombe
Tracey Evans
P2860
P304
e341S-e368S
P356
10.1378/CHEST.12-2361
P407
P433
P577
2013-05-01T00:00:00Z